Autoimmunity and Autoinflammation: From Genes and Cells to Tissues and Therapies

Feb 13–16, 2028 | Fairmont Monte Carlo, Monte Carlo, Monaco
Scientific Organizers: Christopher D. Buckley, Ellen M. Gravallese, and Luke Devey

  Livestream
  In Person
  On Demand
×

-

Feb 13–16, 2028 | Fairmont Monte Carlo, Monte Carlo, Monaco

Scientific Organizers: Christopher D. Buckley, Ellen M. Gravallese, and Luke Devey

Supported by:  

***Meeting program subject to change.

Available Formats:     = Livestream   = In Person     = On Demand
Sunday, February 13, 2028
Registration
4:00–8:00 PM
Welcome Mixer
6:00–8:00 PM
Monday, February 14, 2028
Breakfast
7:30–8:30 AM
Poster Setup
8:00–8:30 AM
Poster Viewing
8:15–5:00 PM
Welcome Remarks
8:30–8:40 AM
Keynote Address
8:40–9:30 AM
Carl H June †, University of Pennsylvania
From Autologous CAR-T to Programmable Immune Reset: The Next Era of Cell Therapy in Autoimmunity
From Genetic Architecture to Causal Cell States and Therapeutic Hypotheses
9:30–11:45 AM
Sophie Hambleton, Newcastle University
Inborn Errors of Immunity as Windows into Autoimmunity and Autoinflammation
Speaker to be Announced
James C. Lee, Francis Crick Institute
From Genetic Risk to Pathogenic Macrophage Programs: ETS2 and Therapeutic Targets in IBD
Short Talk(s) Chosen from Abstracts
Coffee Break
10:00–10:20 AM
Lunch
11:45–12:45 PM
Posters
12:30–2:30 PM
Symposia Spotlight 1: Data-Driven Approaches to Tissue Immunity in Autoimmune and Inflammatory Disease
2:30–4:30 PM
Short Talks Chosen from Abstracts
Coffee Available
4:30–5:00 PM
Innate and Barrier Immune Circuits that Initiate and Sustain Disease
5:00–7:00 PM
Charlotte Odendall, King's College London
Interferon and Innate Signalling at Mucosal Barriers: From Host Defence to Inflammation
Megan T. Baldridge †, Washington University School of Medicine
Microbiota–Innate Immune Circuits in Barrier Inflammation
Eva Frickel †, University of Geneva
Cell-Intrinsic Immunity and Intracellular Stress: New Entry Points into Chronic Inflammation
Short Talk(s) Chosen from Abstracts
On Own for Dinner
7:00–8:00 PM
Tuesday, February 15, 2028
Breakfast
7:30–8:30 AM
Poster Setup
8:00–8:30 AM
Poster Viewing
8:15–5:00 PM
From Mechanism to Patient Stratification and Disease Interception
8:30–11:30 AM
Ellen M. Gravallese, Brigham and Women's Hospital
Tissue Damage, Repair, and Therapeutic Response in Inflammatory Arthritis
Saurabh Mehandru, Icahn School of Medicine
Human Tissue Immunity in IBD: Linking Mucosal Cell States to Treatment Response
Pablo Pelegrin, University of Murcia
From Inflammasome Biology to Biomarkers, Patient Stratification, and Targeted Therapy
Speaker to be Announced
Short Talk(s) Chosen from Abstracts
Coffee Break
9:30–9:50 AM
Lunch
11:30–12:30 PM
Posters
1:00–3:00 PM
Career Roundtable
3:00–4:30 PM
Coffee Available
4:30–5:00 PM
Resetting Tissue Homeostasis - Regulatory Pathways, Stromal Circuits, and Fibrosis
5:00–7:00 PM
Christopher D. Buckley, Kennedy Institute of Rheumatology
The Cellular Basis of persistent Inflammation and its Location: From Tissue Niches to Therapeutic Targets
Jo L Viney, Seismic Therapeutic
Immune Agonism and Regulatory Pathways as Therapeutic Strategies in Autoimmunity
Adam P Croft, University of Birmingham
Resetting the Tissue: Targeting Fibroblasts to Provide New Medicines for Fibrotic and Autoimmune Disease
Short Talk(s) Chosen from Abstracts
On Own for Dinner
7:00–8:00 PM
Wednesday, February 16, 2028
Breakfast
7:30–8:30 AM
Immune Reset in the Clinic - CAR-T, T-Cell Engagers, and Engineered Tolerance
8:30–11:30 AM
Georg A Schett, Uniklinikum Erlangen
Deep B-Cell Depletion and Immune Reset with CAR-T in Lupus and Systemic Sclerosis
Jeff Jones †, Cullinan Therapeutics
Off-the-Shelf Immune Reset with CD19- and BCMA-Directed T-Cell Engagers in Autoimmune Disease
Luke Devey, Quell Therapeutics
Engineered Regulatory T Cells: Can Tolerance Replace Depletion?
Aimee S. Payne †, Columbia University
Antigen-Specific Cellular Therapy for Autoantibody-Mediated Disease: From CAAR-T to Next-Generation Immune Engineering
Short Talk(s) Chosen from Abstracts
Coffee Break
9:30–9:50 AM
Panel Discussion: From First-in-Human to Practice - Ethics, Regulation, Manufacturing, Access, and Long-Term Follow-Up
11:40–12:40 PM
Lunch
12:40–1:40 PM
Symposia Spotlight 2: Next-Generation Immune Engineering and Therapeutic Platforms
2:30–4:30 PM
Short Talks Chosen from Abstracts
Coffee Available
4:30–5:00 PM
Beyond First-Generation CAR-T - In Vivo, Allogeneic, and Myeloid Cell Engineering
5:00–6:45 PM
Laura K. Shawver †, Birdseye Therapeutics
In Vivo CAR-T for Autoimmunity: Turning Cell Therapy into a Scalable, Off-the-Shelf Medicine
Blake Aftab †, Adicet Bio, Inc.
Allogeneic Gamma-Delta CAR-T for Lupus and Systemic Sclerosis: Toward an Off-the-Shelf Immune Reset
Saar I. Gill †, University of Pennsylvania
Engineering Myeloid Cells to Reprogram Fibrotic and Inflamed Tissues
Short Talk(s) Chosen from Abstracts
Meeting Wrap-Up: Outcomes and Future Directions
6:45–7:00 PM
On Own for Dinner
7:00–8:00 PM
Thursday, February 17, 2028
Departure
12:00–11:59 PM

Subscribe for Updates